PUBLIC CONTRACT · 2020
Bevacizumab (25 mg/ml sol inj fr 4 ml IV + 25 mg/ml sol inj fr 16 ml IV) - P259-2020-056
- Contract value
- €52,579.20
- Signed on
- 17 April 2020
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 6862010PUBLISHED SUBJECT
51047120 - AQUISIÇÃO DE BEVACIZUMAB (25 MG/ML SOL INJ FR 4 ML IV + 25 MG/ML SOL INJ FR 16 ML IV) - P259-2020-056
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Roche · Tax ID 500233810
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €52,579.20
- Procedure base price
- €52,579.20
- Total effective price
- Not reported on Portal BASE
- Publication date
- 19 August 2020
- Award date
- 17 April 2020
- Signing date
- 17 April 2020
- Performance period
- 259 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Preço ou custo
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2017/6 - Acordo Quadro para fornecimento de Medicamentos do Foro Oncológico e Imunomoduladores, às Instituições e Serviços do Serviço Nacional de Saúde
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4662491
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.